Logo - springer
Slogan - springer

Chemistry - Biotechnology | 3 Biotech - incl. option to publish open access (Societies)

We’re working on a new version of this journal site - preview it now
3 Biotech

3 Biotech

Executive Editor-in-Chief: Bharat Patel
Editors-in-Chief: Futwan A. A. Al-Mohanna

ISSN: 2190-5738 (electronic version)

Journal no. 13205

361,79 € Personal Rate e-only
Get Subscription

Online subscription, valid from January through December of current calendar year

Immediate access to this year's issues via SpringerLink

Volume(-s) with issue(-s) per annual subscription

Automatic annual renewal

More information: >> FAQs // >> Policy

King Abdulaziz City for Science and Technology

King Abdulaziz City for Science and Technology (KACST) is an independent scientific organization administratively reporting to the Prime Minister. KACST is both the Saudi Arabian national science agency and its national laboratories. The science agency function involves science and technology policy making, data collection, funding of external research, and services such as the patent office.
KACST has partnered with Springer to publish a suite of international journals to foster the development of key applied technologies, providing a forum for the dissemination of research advances and successes from the Kingdom of Saudi Arabia and the world.

Read this Journal on Springerlink

For authors and editors

  • Journal Citation Reports®
    2018 Impact Factor
  • 1.786
  • Aims and Scope

    Aims and Scope


    3 Biotech publishes the results of the latest research related to the study and application of biotechnology to:

    - Medicine and Biomedical Sciences
    - Agriculture
    - The Environment

    The focus on these three technology sectors recognizes that complete Biotechnology applications often require a combination of techniques. 3 Biotech  not only presents the latest developments in biotechnology but also addresses the problems and benefits of integrating a variety of techniques for a particular application. 3 Biotech appeals to scientists and engineers in both academia and industry focusing on the safe and efficient application of Biotechnology to Medicine, Agriculture and the Environment.

    Articles from a huge variety of biotechnology applications are welcome including:

    - Cancer and stem cell research
    - Genetic engineering and cloning
    - Bioremediation and biodegradation
    - Bioinformatics and system biology
    - Biomarkers and biosensors
    - Biodiversity and biodiscovery
    - Biorobotics and biotoxins
    - Analytical biotechnology and the human genome

    3 Biotech accepts original and review articles as well as short research reports, protocols and methods, notes to the editor, letters to the editor and book reviews for publication. Up to date topical review articles will also be considered. All the manuscripts are peer-reviewed for scientific quality and acceptance.

    3 Biotech has recently received its first Impact Factor and is now covered by a range of A&I services, including:

    - Science Citation Index Expanded
    - Journal Citation Reports/Science Edition
    - Biological Abstracts
    - BIOSIS Previews

    3 Biotech publishes under the Continuous Article Publishing (CAP) in which accepted papers are published online with volume and article numbers shortly after receipt of authors proofs. CAP aims to speed up the process from acceptance of articles to final publication without the need for articles to be placed in a waiting line. This will ensure that all articles in 3 Biotech are immediately available for researchers in relevant indexing and abstracting databases.

  • Submit Online
  • Open Choice - Your Way to Open Access
  • General Instructions for Authors

    Instructions for Authors


  • Specific Instruction for Authors (pdf, 1...

Services for the Journal

Alerts for this journal


Get the table of contents of every new issue published in 3 Biotech.

Additional information